Relay Therapeutics Inc (RLAY)

$6.86 +0.10 (1.48%)
Market Cap 1.18B
Revenue (ttm) 10.01M
Net Income (ttm) -337.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,373.73%
Debt to Equity Ratio 0.00
Volume 3,277,000
Avg Vol 1,566,748
Day's Range N/A - N/A
Shares Out 172.41M
Stochastic %K 61%
Beta 1.75
Analysts Strong Sell
Price Target $13.60

Company Profile

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGa...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 370 8837
Address:
399 Binney Street, 2nd Floor, Cambridge, United States
ObeCalp
ObeCalp Oct. 25 at 12:15 AM
$RLAY Adding $KNSA to the "fishy" bucket.
0 · Reply
ObeCalp
ObeCalp Oct. 24 at 8:40 PM
$RLAY Fishy volume. Monday will be interesting.
0 · Reply
WycklyTrader
WycklyTrader Oct. 24 at 7:53 PM
$QNCX CGEM potential base breakout with upcoming FDA catalysts. 52wk high swingS: $NUVB $RLAY $TOI $FDMT ...
0 · Reply
Nikkosi
Nikkosi Oct. 20 at 7:19 PM
$RLAY She is moving in silence 🤫 love it.
1 · Reply
Breck100
Breck100 Oct. 20 at 4:20 PM
$RLAY 10/20/25 Barclays analyst Peter Lawson maintained a Buy rating on Relay Therapeutics today and set a price target of $17.00. The company’s shares closed last Friday at $6.49.
0 · Reply
MisterNessuno
MisterNessuno Oct. 10 at 3:19 PM
$PACB Come to $RLAY and wait some week
0 · Reply
Awiz2
Awiz2 Oct. 10 at 12:36 PM
$RLAY Energy is changing . Looks and feels like big run about to happen! $$$$
0 · Reply
CrAzYtRaDeR2020
CrAzYtRaDeR2020 Oct. 9 at 2:07 PM
$RLAY rlay about to breakout! With $15 dollar price target and breakthrough news last month.
3 · Reply
Megaduffman
Megaduffman Oct. 7 at 8:28 PM
$RLAY
0 · Reply
mdemattia
mdemattia Oct. 5 at 12:45 AM
$RLAY Breast cancer trial info must be leaking to the hedge fund guys. Also, RLAY on the Goldman Sachs m&a list helps too. Finally, technical signals are positive which motivates the day traders. I’m pleased.
2 · Reply
Latest News on RLAY
Relay Therapeutics Is A Buy For Its Superb Safety Data

Oct 24, 2025, 1:21 PM EDT - 2 days ago

Relay Therapeutics Is A Buy For Its Superb Safety Data

Relay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 2:33 PM EDT - 6 weeks ago

Relay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Aug 28, 2025, 4:05 PM EDT - 2 months ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates

Aug 7, 2025, 4:05 PM EDT - 2 months ago

Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates

Relay Therapeutics: What's Next For H2 2025?

Aug 2, 2025, 8:03 AM EDT - 3 months ago

Relay Therapeutics: What's Next For H2 2025?

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

Jul 31, 2025, 4:05 PM EDT - 3 months ago

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Jun 11, 2025, 4:05 PM EDT - 4 months ago

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025

Jun 2, 2025, 7:00 AM EDT - 5 months ago

Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

May 29, 2025, 4:05 PM EDT - 5 months ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

May 8, 2025, 4:05 PM EDT - 6 months ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

May 5, 2025, 4:05 PM EDT - 6 months ago

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Apr 28, 2025, 4:05 PM EDT - 6 months ago

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Relay Therapeutics: Trying To Find That Right Price

Apr 12, 2025, 9:28 AM EDT - 7 months ago

Relay Therapeutics: Trying To Find That Right Price

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Feb 26, 2025, 4:05 PM EST - 8 months ago

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025

Feb 19, 2025, 4:05 PM EST - 8 months ago

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025

Relay Therapeutics: A Precision Oncology Play Worth The Risk

Feb 14, 2025, 2:17 AM EST - 9 months ago

Relay Therapeutics: A Precision Oncology Play Worth The Risk

Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 4:05 PM EST - 10 months ago

Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

Dec 11, 2024, 6:00 AM EST - 11 months ago

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

Dec 9, 2024, 4:05 PM EST - 11 months ago

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Dec 3, 2024, 8:01 AM EST - 11 months ago

Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Dec 3, 2024, 8:00 AM EST - 11 months ago

Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

Nov 6, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

Oct 30, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

Relay Therapeutics: 2nd-Line RLY-2608 Data Moves Program Towards Expansion

Sep 16, 2024, 4:57 PM EDT - 1 year ago

Relay Therapeutics: 2nd-Line RLY-2608 Data Moves Program Towards Expansion

Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations

Sep 11, 2024, 8:15 AM EDT - 1 year ago

Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations

GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Sep 11, 2024, 8:06 AM EDT - 1 year ago

GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

GME WOOF

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Sep 10, 2024, 8:21 PM EDT - 1 year ago

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market

Sep 10, 2024, 2:50 PM EDT - 1 year ago

Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market

This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Sep 10, 2024, 10:03 AM EDT - 1 year ago

This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

JCI DK EQR ORCL

Relay Therapeutics Announces Proposed Public Offering of Common Stock

Sep 9, 2024, 4:34 PM EDT - 1 year ago

Relay Therapeutics Announces Proposed Public Offering of Common Stock

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher

Sep 9, 2024, 2:16 PM EDT - 1 year ago

Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher

Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients

Sep 9, 2024, 11:30 AM EDT - 1 year ago

Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients

Relay Therapeutics' combo therapy for breast cancer cuts disease progression in early study

Sep 9, 2024, 7:04 AM EDT - 1 year ago

Relay Therapeutics' combo therapy for breast cancer cuts disease progression in early study

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Sep 9, 2024, 6:55 AM EDT - 1 year ago

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

Sep 6, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

Jun 6, 2024, 7:00 AM EDT - 1 year ago

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

Jun 5, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

Relay Therapeutics to Participate in Upcoming Investor Conferences

May 21, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics to Participate in Upcoming Investor Conferences

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

May 13, 2024, 8:30 AM EDT - 1 year ago

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

May 2, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

Apr 25, 2024, 4:05 PM EDT - 1 year ago

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

Feb 26, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

Feb 22, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

Feb 15, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Feb 1, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Relay Therapeutics Announces $30 Million Private Placement Financing

Jan 8, 2024, 7:00 AM EST - 1 year ago

Relay Therapeutics Announces $30 Million Private Placement Financing

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 4:05 PM EST - 1 year ago

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

Nov 7, 2023, 4:05 PM EST - 2 years ago

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

Relay Therapeutics: Market Is Underestimating Lirafugratinib's Potential (Rating Upgrade)

Nov 6, 2023, 2:05 AM EST - 2 years ago

Relay Therapeutics: Market Is Underestimating Lirafugratinib's Potential (Rating Upgrade)

ObeCalp
ObeCalp Oct. 25 at 12:15 AM
$RLAY Adding $KNSA to the "fishy" bucket.
0 · Reply
ObeCalp
ObeCalp Oct. 24 at 8:40 PM
$RLAY Fishy volume. Monday will be interesting.
0 · Reply
WycklyTrader
WycklyTrader Oct. 24 at 7:53 PM
$QNCX CGEM potential base breakout with upcoming FDA catalysts. 52wk high swingS: $NUVB $RLAY $TOI $FDMT ...
0 · Reply
Nikkosi
Nikkosi Oct. 20 at 7:19 PM
$RLAY She is moving in silence 🤫 love it.
1 · Reply
Breck100
Breck100 Oct. 20 at 4:20 PM
$RLAY 10/20/25 Barclays analyst Peter Lawson maintained a Buy rating on Relay Therapeutics today and set a price target of $17.00. The company’s shares closed last Friday at $6.49.
0 · Reply
MisterNessuno
MisterNessuno Oct. 10 at 3:19 PM
$PACB Come to $RLAY and wait some week
0 · Reply
Awiz2
Awiz2 Oct. 10 at 12:36 PM
$RLAY Energy is changing . Looks and feels like big run about to happen! $$$$
0 · Reply
CrAzYtRaDeR2020
CrAzYtRaDeR2020 Oct. 9 at 2:07 PM
$RLAY rlay about to breakout! With $15 dollar price target and breakthrough news last month.
3 · Reply
Megaduffman
Megaduffman Oct. 7 at 8:28 PM
$RLAY
0 · Reply
mdemattia
mdemattia Oct. 5 at 12:45 AM
$RLAY Breast cancer trial info must be leaking to the hedge fund guys. Also, RLAY on the Goldman Sachs m&a list helps too. Finally, technical signals are positive which motivates the day traders. I’m pleased.
2 · Reply
Breck100
Breck100 Oct. 3 at 7:11 PM
$RLAY I'm not sure what's happening here, but I like it a lot. Let's go $RLAY
1 · Reply
atxtrader
atxtrader Oct. 1 at 4:18 PM
$RLAY $ALT Both of these trades are setting up nicely for the end of the year.
0 · Reply
Megaduffman
Megaduffman Oct. 1 at 2:32 PM
$RLAY $CAPR
0 · Reply
MisterNessuno
MisterNessuno Sep. 30 at 4:41 PM
$RVSN come to $RLAY
0 · Reply
SweepCastApp
SweepCastApp Sep. 28 at 2:35 PM
$RLAY: Unusual Options Activity Alerted CALL flow observed 6379x contracts at Strike price of $7.5 Exp on 12/19/2025 with Premium of $191K and showing BULLISH Sentiment
0 · Reply
SweepCastApp
SweepCastApp Sep. 27 at 5:19 AM
$RLAY: TRADE CALL activity detected 6379 @ 0.30 Strike 7.5 Exp 12/19/2025 Premium $191.4K Sentiment BULLISH
1 · Reply
mdemattia
mdemattia Sep. 27 at 2:49 AM
$RLAY from your lips to Gods ear
2 · Reply
Bullishbruk
Bullishbruk Sep. 27 at 12:05 AM
$RLAY 45k @3.65 been holding almost a year let us go
1 · Reply
BigDaddyCapital
BigDaddyCapital Sep. 26 at 10:26 PM
$RLAY News leak on getting acquired?
1 · Reply
Breck100
Breck100 Sep. 26 at 7:50 PM
$RLAY LFG
0 · Reply
StockConsultant
StockConsultant Sep. 19 at 4:28 AM
$RLAY Relay Therapeutics stock, nice bull flag breakout at https://stockconsultant.com/?RLAY
0 · Reply
Ohzipit
Ohzipit Sep. 18 at 5:35 PM
$RLAY RJF update from early August. Strong Buy base case $19
0 · Reply